Stockreport

Sol-Gel Provides Update Following Unblinding of Phase 1b Study of SGT-210 in Darier Disease

Sol-Gel Technologies Ltd. - Ordinary Shares  (SLGL) 
Last sol-gel technologies ltd. - ordinary shares earnings: 11/13 07:05 am Check Earnings Report
PDF NESS ZIONA, Israel, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company, pioneering treatments for patients with rare an [Read more]